BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 35515695)

  • 1. Potential metabolism determinants and drug-drug interactions of a natural flavanone bavachinin.
    Li X; Xing H; Qin Z; Yang J; Wang P; Zhang X; Yao Z; Yao X
    RSC Adv; 2020 Sep; 10(58):35141-35152. PubMed ID: 35515695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An investigation of the metabolic activity, isozyme contribution, species differences and potential drug-drug interactions of PI-103, and the identification of efflux transporters for PI-103-
    Gao L; Qin Z; Zhang B; Yin Z; Zhang X; Yang J
    RSC Adv; 2020 Mar; 10(16):9610-9622. PubMed ID: 35497201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolism and disposition of corylifol A from
    Li Y; Xu J; Xu C; Qin Z; Li S; Hu L; Yao Z; Gonzalez FJ; Yao X
    Xenobiotica; 2020 Aug; 50(8):997-1008. PubMed ID: 32116078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of metabolic activity, isozyme contribution and species differences of bavachin, and identification of efflux transporters for bavachin-O-glucuronide in HeLa1A1 cells.
    Li Y; Xu C; Xu J; Qin Z; Li S; Hu L; Yao Z; Gonzalez FJ; Yao X
    J Pharm Pharmacol; 2020 Dec; 72(12):1771-1786. PubMed ID: 32648321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation on the metabolic characteristics of isobavachin in Psoralea corylifolia L. (Bu-gu-zhi) and its potential inhibition against human cytochrome P450s and UDP-glucuronosyltransferases.
    Xing H; Yang J; Ren K; Qin Z; Wang P; Zhang X; Yao Z; Gonzalez FJ; Yao X
    J Pharm Pharmacol; 2020 Dec; 72(12):1865-1878. PubMed ID: 32750744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential Determinants for Metabolic Fates and Inhibitory Effects of Isobavachalcone Involving in Human Cytochrome P450, UDP-Glucuronosyltransferase Enzymes, and Efflux Transporters.
    Qin Z; Wang P; Duan S; Wan X; Xing H; Yang J; Zhang X; Yao Z; Yao X
    J Pharm Sci; 2021 May; 110(5):2285-2294. PubMed ID: 33610566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of UGTs and BCRP as potential pharmacokinetic determinants of the natural flavonoid alpinetin.
    Qi C; Fu J; Zhao H; Xing H; Dong D; Wu B
    Xenobiotica; 2019 Mar; 49(3):276-283. PubMed ID: 29436891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Study on metabolic dynamics,metabolic enzyme phenotype and species difference of hepatic and intestinal microsome of psoralidin].
    Qin ZF; Zhang BB; Xing H; Wang PL; Yang J; Zhang XJ; Yao ZH; Yao XS
    Zhongguo Zhong Yao Za Zhi; 2021 Jul; 46(13):3410-3421. PubMed ID: 34396762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contributions of UDP-Glucuronosyltransferases to Human Hepatic and Intestinal Metabolism of Ticagrelor and Inhibition of UGTs and Cytochrome P450 Enzymes by Ticagrelor and its Glucuronidated Metabolite.
    Liu S; Hou L; Li C; Zhao Y; Yao X; Zhang X; Tian X
    Front Pharmacol; 2021; 12():761814. PubMed ID: 34721047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitrometabolic mapping of neobavaisoflavone in human cytochromes P450 and UDP-glucuronosyltransferase enzymes by ultra high-performance liquid chromatography coupled with quadrupole time-of-flight tandem mass spectrometry.
    Xu J; Li M; Yao Z; Zhang Y; Li S; Hu L; Qin Z; Gonzalez FJ; Yao X
    J Pharm Biomed Anal; 2018 Sep; 158():351-360. PubMed ID: 29933228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In Vitro Characterization of Ertugliflozin Metabolism by UDP-Glucuronosyltransferase and Cytochrome P450 Enzymes.
    Lapham K; Callegari E; Cianfrogna J; Lin J; Niosi M; Orozco CC; Sharma R; Goosen TC
    Drug Metab Dispos; 2020 Dec; 48(12):1350-1363. PubMed ID: 33020067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regioselective glucuronidation of the isoflavone calycosin by human liver microsomes and recombinant human UDP-glucuronosyltransferases.
    Ruan JQ; Yan R
    Chem Biol Interact; 2014 Sep; 220():231-40. PubMed ID: 25044472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct comparison of UDP-glucuronosyltransferase and cytochrome P450 activities in human liver microsomes, plated and suspended primary human hepatocytes from five liver donors.
    den Braver-Sewradj SP; den Braver MW; Baze A; Decorde J; Fonsi M; Bachellier P; Vermeulen NPE; Commandeur JNM; Richert L; Vos JC
    Eur J Pharm Sci; 2017 Nov; 109():96-110. PubMed ID: 28778465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucuronidation of DRF-6574, hydroxy metabolite of DRF-4367 (a novel COX-2 inhibitor) by pooled human liver, intestinal microsomes and recombinant human UDP-glucuronosyltransferases (UGT): role of UGT1A1, 1A3 and 1A8.
    Muzeeb S; Basha SJ; Shashikumar D; Mullangi R; Srinivas NR
    Eur J Drug Metab Pharmacokinet; 2006; 31(4):299-309. PubMed ID: 17315542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and characterization of human UDP-glucuronosyltransferases responsible for the in-vitro glucuronidation of arctigenin.
    Xin H; Xia YL; Hou J; Wang P; He W; Yang L; Ge GB; Xu W
    J Pharm Pharmacol; 2015 Dec; 67(12):1673-81. PubMed ID: 26407805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tissue and species differences in the glucuronidation of glabridin with UDP-glucuronosyltransferases.
    Guo B; Fang Z; Yang L; Xiao L; Xia Y; Gonzalez FJ; Zhu L; Cao Y; Ge G; Yang L; Sun H
    Chem Biol Interact; 2015 Apr; 231():90-7. PubMed ID: 25765239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucuronidation of edaravone by human liver and kidney microsomes: biphasic kinetics and identification of UGT1A9 as the major UDP-glucuronosyltransferase isoform.
    Ma L; Sun J; Peng Y; Zhang R; Shao F; Hu X; Zhu J; Wang X; Cheng X; Zhu Y; Wan P; Feng D; Wu H; Wang G
    Drug Metab Dispos; 2012 Apr; 40(4):734-41. PubMed ID: 22238289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemical inhibition and stable knock-down of efflux transporters leads to reduced glucuronidation of wushanicaritin in UGT1A1-overexpressing HeLa cells: the role of breast cancer resistance protein (BCRP) and multidrug resistance-associated proteins (MRPs) in the excretion of glucuronides.
    Qin Z; Li S; Yao Z; Hong X; Wu B; Krausz KW; Gonzalez FJ; Gao H; Yao X
    Food Funct; 2018 Mar; 9(3):1410-1423. PubMed ID: 29318243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucuronidation of OTS167 in Humans Is Catalyzed by UDP-Glucuronosyltransferases UGT1A1, UGT1A3, UGT1A8, and UGT1A10.
    Ramírez J; Mirkov S; House LK; Ratain MJ
    Drug Metab Dispos; 2015 Jul; 43(7):928-35. PubMed ID: 25870101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of UDP-glucuronosyltransferases involved in glucuronidation of diethylstilbestrol in human liver and intestine.
    Zhu L; Ge G; Liu Y; Guo Z; Peng C; Zhang F; Cao Y; Wu J; Fang Z; Liang X; Yang L
    Chem Res Toxicol; 2012 Dec; 25(12):2663-9. PubMed ID: 23126256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.